-
Anxiety is a common but underrecognized symptom of Parkinson's disease, for which there are a number of suggested but no recommended rating scales.
-
Fourteen cases of the rare and difficult to treat "painful legs and moving toes" syndrome are presented. The cases included diverse etiologies—polyneuropathy, radiculopathy, or neuroleptic use—and half responded to GABAergic medications.
-
Axonal sensory neuropathy is a common complication of thalidomide therapy and occurs at a lower than expected dose in patients with cutaneous lupus.
-
Needle EMG is a safe procedure in patients who are taking antiplatelet or warfarin therapy.
-
-
Neuromyelitis optica (NMO) may be a unique central nervous system demyelinating disease with distinct clinical and MRI manifestations, as well as different immune and pathological characteristics as compared to multiple sclerosis (MS).
-
Aspirin plus extended-release dipyridamole and clopidogrel are both appropriate options to decrease disability from recurrent stroke; however, telmisartan does not lower risk of suffering a second stroke.
-
Statins may cause worsening symptoms in patients with myasthenia gravis.
-
Ongoing safety review of tiotropium; raloxifene reduces the risk of endometrial cancer; one-day treatment with famciclovir may be as effective as 3-day treatment with valacyclovir; new Clinical Practice Guideline from the American College of Physicians regarding pharmacologic treatment for low bone density and osteoporosis; FDA Actions.
-
Intravenous thrombolysis is safe and effective for the treatment of ischemic stroke in the time window of 3-4.5 hours after the onset of symptoms.
